Flu Season Warning: Timelines Matter

Schoolchildren wearing masks raise hands in a classroom
Photo: Prostock-studio / Shutterstock

Federal health officials say nearly every American over six months old should get a flu shot this fall, and for the first time, adults 50 to 64 have a brand-new mRNA option to choose from.

Quick Take

  • The Centers for Disease Control and Prevention (CDC) recommends annual flu vaccination for almost everyone age 6 months and up, with rare exceptions.
  • A new mRNA flu vaccine called MFLUSIVA is now approved for adults 50 and older, adding to older vaccine options.
  • The CDC says the best time to get vaccinated is September or October, before flu season peaks.
  • Real-world protection varies widely by season and age, ranging from roughly 35% to 44% depending on the year and outcome measured.

What the Government Actually Recommends This Season

The CDC’s guidance is simple on paper: get a flu shot every year if you’re 6 months or older. The agency calls exceptions rare, covering people with specific medical conditions or past severe reactions. For adults 65 and older, the CDC prefers higher-dose, recombinant, or adjuvanted vaccines, since older immune systems often respond more weakly to standard shots. All vaccines for the 2026–2027 season are trivalent, meaning they target three strains instead of four.

Massachusetts public health guidance echoes the federal advice but adds detail for specific groups. Pregnant women, transplant patients, and people with weakened immune systems each have product-specific recommendations that a pharmacist or doctor can walk through in minutes. The message isn’t “pick any shot.” It’s “pick the right shot for your situation,” which is why officials keep pointing people back to a conversation with their provider rather than a one-size-fits-all poster.

New Options Join the Vaccine Lineup for Adults 50 and Older

The biggest change this season is MFLUSIVA, a messenger RNA flu vaccine. The Food and Drug Administration (FDA) gave it traditional approval for adults 50 to 64 and accelerated approval for those 65 and older. It’s the first mRNA flu shot to reach the market, built on the same technology that powered COVID-19 vaccines. Local news stations across the country, from Chicago to New Orleans to New York, have covered the rollout as patients and pharmacists sort out where it’s stocked.

Availability and insurance coverage for the new shot are still catching up to demand in some areas. That’s not unusual for a first-year product. Traditional inactivated and recombinant flu vaccines remain widely available at pharmacies and clinics nationwide, and the CDC’s core message hasn’t changed: get vaccinated with whatever appropriate option your provider recommends, sooner rather than later.

Why Effectiveness Numbers Bounce Around Every Year

Flu shots don’t offer a fixed level of protection the way some vaccines do, because the flu virus mutates constantly. During the 2021–2022 season, the CDC found vaccination cut the risk of mild-to-moderate illness from one flu strain by about 35%. A separate meta-analysis of studies from 2017 to 2022 put overall effectiveness against medically attended flu at roughly 41%. Protection against hospitalization has measured even higher in some studies, around 43%.

These numbers aren’t contradictory. They reflect different seasons, different age groups, and different outcomes being measured, flu illness versus hospitalization versus a specific strain. The honest takeaway is that flu vaccines reduce risk significantly without eliminating it entirely, and how much protection you get depends on how well that year’s vaccine matches the circulating virus.

Safety Record and the Rare Risks Worth Knowing

Decades of surveillance back up the vaccine’s safety profile. The CDC tracks a rare nerve condition called Guillain-Barré syndrome, and in seasons where a slightly increased risk shows up, it amounts to about one or two extra cases per million vaccinated people. That’s an exceptionally small number compared to the hundreds of thousands of flu-related hospitalizations the CDC tracks most years.

Emergency physicians who treat severe flu cases say the stakes are real for unvaccinated patients, even if any single story can’t prove population-wide statistics on its own. The practical advice stays consistent across every official source: talk to your doctor or pharmacist about which vaccine fits your age and health history, then get it done before flu activity picks up in your community this fall.

Sources:

youtube.com, cdc.gov, fda.gov, mass.gov, sciencedirect.com